Class of 2019 Residency Matches and Fellows

Lauren Antal, Pharm. D., is one of the current PGY-1 residents at Holy Cross Hospital in Silver Spring, Maryland. Her current research involves opioid stewardship. Her interests include critical care, oncology, and pain management and palliative care. t

Emily Biskach, Pharm. D., is currently a PGY1 Community Pharmacy Resident at University of Maryland Eastern Shore and Apple Discount Drugs. Her current research project involves patients with diabetes who are not currently on statin therapy. Her interests include academia, ambulatory care, sterile and nonsterile compounding. t

tEmily Diseroad, Pharm. D., a PGY-1 resident at Johns Hopkins Medical Center.

tMarc Etone Nkwelle, Pharm. D., is a current PGY-1 Pharmacy Resident at Bayhealth Medical Center. Upon completion of his PGY-1 pharmacy residency, he hopes to pursue further training in a PGY-2 residency of his interest.

Victoria Hearn, Pharm. D., is currently a PGY-1 Pharmacy Practice Resident at Peninsula Regional Medical Center. At the ASHP Midyear Clinical Meeting, she and her coresident presented their research on intrapleural dornase and alteplase for the treatment of empyema and pleural effusions. Her individual research involves the evaluation of fluoroquinolone use for uncomplicated infections. Victoria’s interests include critical care and infectious disease. t

Shelby Holstein, Pharm. D. In her current role as a fellow at the FDA, Dr. Holstein is involved in internal, external and collaborative research initiatives to evaluate the feasibility of alternative and scientifically valid methods to demonstrate bioequivalence for topical, transdermal, rectal, vaginal, and urethral drug products. Additionally, her and her team analyze this data, and review drug applications, to write and develop product specific guidance’s (PSGs). This month Dr. Holstein will be presenting a collaborative research poster during the FDA’s Generic Drug Science Day. She is grateful for this opportunity and looks forward to continuing to learn more about the science and formulation considerations that go into developing complex drug products, while helping to bring more generic topical dermatological drug products to market. t

Lilai Tetum, Pharm. D., currently has a role in the Office of Consumer Medical Safety as a Fellow at Johnson & Johnson. t